|1.||Liu, Ping: 6 articles (01/2012 - 08/2002)|
|2.||Tian, Jingwei: 5 articles (08/2013 - 03/2009)|
|3.||Liu, Cheng-Hai: 5 articles (07/2013 - 08/2002)|
|4.||Xu, Feng: 4 articles (02/2015 - 01/2010)|
|5.||Guo, De-An: 4 articles (02/2015 - 04/2011)|
|6.||Liu, Xuan: 4 articles (02/2015 - 04/2011)|
|7.||Deng, Yanping: 4 articles (02/2015 - 01/2010)|
|8.||Jiang, Baohong: 4 articles (02/2015 - 01/2010)|
|9.||Gao, Yubai: 4 articles (08/2013 - 03/2009)|
|10.||Xu, Lie-Ming: 4 articles (12/2012 - 08/2002)|
05/01/2009 - "While Salvianolic acid-B (Sal B) has been well appreciated to show a protective effect of tissue fibrosis, the objective of this study was to investigate the influence of Sal B on the transdifferentiation of renal tubular epithelial cells. "
07/01/2005 - "To study the therapeutic mechanism of salvianolic acid B (SA-B) in treating hepatic fibrosis. "
12/18/2012 - "Inhibitory effects of salvianolic acid B on CCl(4)-induced hepatic fibrosis through regulating NF-κB/IκBα signaling."
11/01/2010 - "[Protection and mechanisms of salvianolic-acid B on experimental renal interstitial fibrosis in rats]."
11/01/2009 - "[Effect of salvianolic acid B on generation and activation of myofibroblast in rat with renal interstitial fibrosis]."
02/01/2012 - "To study the protective effect and mechanism of salvianolic acid B on isolated heart ischemia/reperfusion injury in rats. "
02/01/2012 - "[Protective effect of salvianolic acid B on isolated heart ischemia/reperfusion injury in rats]."
04/01/2006 - "Salvianolic acid B (Sal B), a pure compound extracted from SM, has been reported to be effective against fibrosis and ischemia-reperfusion injury, possibly through its anti-lipid peroxidation action. "
01/01/2003 - "Although a pure compound extracted from SM, salvianolic acid B (Sal B), has been reported to be effective against fibrosis and ischemia-reperfusion injury, possibly through its anti-lipid peroxidation action, the effect of SM on angiogenesis remains unclear. "
07/01/2015 - "To investigate the neuroprotective effects and underlying mechanisms of salvianolic acid B (Sal B) extracted from Salvia miltiorrhiza on hippocampal CA1 neurons in mice with cerebral ischemia reperfusion injury. "
|3.||Liver Cirrhosis (Hepatic Cirrhosis)
12/01/2012 - "Previous studies have confirmed that salvianolic acid B (Sal B) is effective against liver fibrosis. "
11/01/2015 - "Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation."
04/01/2011 - "[Effect of salvianolic acid B on CD14 expression in rats with liver fibrosis]."
01/01/2010 - "To investigate the mechanism of salvianolic acid B (Sal B) action against liver fibrosis through preventing lipid peroxidation and regulating MMP-2 activity in liver. "
08/01/2002 - "To investigate the mechanism of salvianolic acid-B (SA-B) action against liver fibrosis relating to mediating hepatic stellate cell (HSC) activation and transforming growth factor-beta1(TGF-beta1) intracellular signal transduction. "
09/01/2006 - "Neural cells in the sensorimotor cortex were also preserved in animals that received salvianolic acid B at a high dose of 10 mg/kg. Salvianolic acid B (10 mg/kg) also improved the integrity of microvessels after ischemia. "
06/01/2009 - "Then the EPCs preconditioned with different concentrations of Salvianolic acid B and BMSc or DMEM medium were implanted into heart ischemia area. "
12/01/2008 - "[Effects of salvianolic acid B on cardiovascular endothelial cells and platelet activation in a rabbit model of ischemia-reperfusion]."
05/01/2000 - "To study the protective effects of salvianolic acid B (Sal B) against the ischemia-reperfusion induced rat brain injury. "
05/01/2012 - "EPCs pretreated by salvianolic acid B combined with BMSCs could reduce the myocardial infarcted area, improve the proliferation of BMSCs in the peripheral infarction and local ischemia. "
|5.||Myocardial Ischemia (Ischemic Heart Diseases)
01/01/2012 - "Salvianolic acid B (SA-B), a water-soluble active component of Danshen, was found to have anti-myocardial ischemia (anti-MI) effect. "
01/01/2012 - "Metabolomic profiles of myocardial ischemia under treatment with salvianolic acid B."
12/01/2008 - "To investigate the effects of salvianolic acid B (SA-B) on cardiovascular endothelial cell function and platelet activation during myocardial ischemia-reperfusion in rabbits. "
04/01/2014 - "Salvianolic acid B has a significant protective effect on myocardial ischemia-reperfusion injury. "
04/01/2014 - "To investigate the effect of salvianolic acid B on rats with myocardial ischemia-reperfusion injury. "
|2.||2- (6- (2- carboxyvinyl)- 2,3- dihydroxyphenyl)- 3- (3,4- dihydroxyphenyl)acrylic acid
|3.||Triamcinolone Acetonide (Azmacort)
|10.||formycin diphosphate (FDP)
|1.||Chinese Traditional Medicine (Traditional Chinese Medicine)
|5.||Transplantation (Transplant Recipients)